Company: NCEL
Filing Date: 2025-09-10
Form Type: 424B3
Source: 0001213900-25-086600
Chunk: 494

Company: NewcelX Ltd.
Filing Date: 2025-09-10
Form: 424B3
Chunk 494
---
,433 related to conversion of loan from related parties as noted above at closing of Merger; (I)Adjustment for $1,511,653 related to conversion of loans from related parties as noted above at closing of Merger; (I)Adjustment for $5,060,872 related to conversion of convertible loan and warrants as noted above at closing of Merger; (I)Adjustment to remove $5,043,768 of interest expense related to loans converted as noted above at closing as if Merger took place January1, 2024, for the twelve months ended December31, 2024; (J)Adjustment to record elimination of $1,238,425 of share premium and $62,560,326 Kadimastem Ordinary Shares, no par value, at the Closing; (K)Adjustments to reflect the modified par value of $159,530 for Preferred Participation Certificates and $2,636,532 for NLS Common Shares as approved on January14, 2025 by the shareholders of NLS from CHF 0.80 to CHF 0.03 per share, effective January17, 2025; (L)Elimination of NLS accumulated deficit of $73,880,474 and accumulated other comprehensive loss of $108,853 at closing of Merger; (M)Adjustment of $1,721,880 to record issuance of 46,032,286 NLS Common Shares to Kadimastem at CHF 0.03 par value upon closing of the Merger to currently represent 83% currently estimated ownership in NLS; (N) To reflect the preliminary allocation in the unaudited pro forma condensed combined financial statements, management has estimated the purchase price allocation based on currently available information. The carrying value of NLS’s net assets is assumed to approximate fair value, and the excess of the purchase consideration over the estimated fair value of those net assets has been preliminarily allocated to intangible assets — specifically, in -processresearch and development (IPR&D) — and goodwill. This allocation is consistent with the guidance 274

of IFRS3, Business Combinations, which requires that identifiable intangible assets and goodwill be recognized at their respective fair values as of the acquisition date. The allocation is subject to change upon completion of the Merger and finalization of the purchase price allocation analysis to be conducted upon Closing of the Merger.

|                                             |     | Amount |            |
|:--------------------------------------------|